Oncology Onward: A Conversation With Dr Shereef Elnahal, Under Secretary for Health

Shereef Elnahal, MD, MBA, under secretary for health at the Veterans Health Administration (VHA), sat for a conversation with our hosts Emeline Aviki, MD, MBA, Memorial Sloan Kettering Cancer Center, and Stephen Schleicher, MD, MBA, Tennessee Oncology, that covered the cancer footprint of the VHA.

Approximately 450,000 veterans every year who are on the cancer continuum, from screening to survivorship; 43,000 new cancer diagnoses every year, approximately 25% of which are rare cancers; and experts in almost every type of cancer and disease site—with contributions in both basic science and translational research, as well as lessons for the broader American health care system from among the only nationwide health care system, which has a total enrollment of 9 million.

These are just a few of the statistics Shereef Elnahal, MD, MBA, under secretary for health at the Veterans Health Administration (VHA), shared when he sat for a conversation with our hosts Emeline Aviki, MD, MBA, gynecologic oncologist at Memorial Sloan Kettering Cancer Center, and Stephen Schleicher, MD, MBA, chief medical officer at Tennessee Oncology, that covered the cancer footprint of the VHA, from work within the newly reinvigorated Cancer Moonshot program and screening for vulnerable communities to the Million Veterans Program, the largest genomic database of its kind in the country and of Black Americans, including information on more than 150,000 Black veterans.

iTunes
TuneIn
Stitcher
Spotify

Related Videos
Mitzi Joi Williams, MD, FAAN, Joi Life Wellness Neurology Clinic
Screenshot of Sancy Leachman, MD, PhD, smiling
Screenshot of Jennifer Sun, MD, MPH
Stephen M. Schleicher, MD, MBA, Tennessee Oncology
Mitzi Joi Williams, MD, FAAN, Joi Life Wellness Neurology Clinic
Mitzi Joi Williams, MD, FAAN, Joi Life Wellness Neurology Clinic
Dr. Nicole Rosendale
Dr. Nicole Rosendale
Mitzi Joi Williams, MD, FAAN, Joi Life Wellness Neurology Clinic
Related Content
© 2023 MJH Life Sciences
AJMC®
All rights reserved.